Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2017


June 1, 2011
65 Pages - SKU: GBDT6505603
License type:
Table of Contents Search inside this report Related Reports Detailed Contents
The World Market for Pain Management Drugs and Devices
5/20/2013 | published by: Kalorama Information
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and  |  read more...
$3,500.00
Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
6/14/2013 | published by: Venture Planning Group
This new 278-page report from Venture Planning Group, Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis , provides analysis of the US sexually-transmitted disease testing market, including emerging  |  read more...
$4,500.00
Triple Analysis: Breast Cancer, Leukemia and Melanoma
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Breast Cancer, Leukemia and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology  |  read more...
$5,175.00
Triple Analysis: Breast Cancer, Lung Cancer and Melanoma
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Breast Cancer, Lung Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment  |  read more...
$5,175.00
Triple Analysis: Breast Cancer, Melanoma and Angiogenesis
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Melanoma and by the mechanism/target/effect of Angiogenesis. Each of these three individual parts is evaluated according to standardized criteria in a  |  read more...
$5,175.00
Triple Analysis: Melanoma, Prostate Cancer and Peptides
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in both Melanoma and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according to standardized criteria in  |  read more...
$5,175.00
Triple Analysis: Melanoma, Antibodies and Peptides
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Melanoma and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according to standardized criteria in a  |  read more...
$5,175.00
Triple Analysis: Breast Cancer, Melanoma and Prostate Cancer
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Breast Cancer, Melanoma and Prostate Cancer. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment  |  read more...
$5,175.00
Triple Analysis: Colorectal Cancer, Leukemia and Melanoma
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Leukemia and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology  |  read more...
$5,175.00
Triple Analysis: Colorectal Cancer, Lung Cancer and Melanoma
6/12/2013 | published by: BioSeeker Group AB
This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lung Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment  |  read more...
$5,175.00
 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Orthopedics Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!